Nancy Curosh
Endocrinology, Diabetes & Metabolism · Portland, ORNPI 1942298187
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,782 of the $59,392 with a category attached, or 83.8%. 20 manufacturers reported payments, led by Boehringer Ingelheim at 44.2% of the total. Reporting peaked in 2019 at $32,710 and has fallen 81.6% since, to $6,018 in 2021.
Across 240 payments — averaging $247.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$26K
- Sanofi-aventis U.S. LLC$23K
- Lilly USA, LLC$9K
- Novo Nordisk$301
- Dexcom, Inc.$159
- Abbott$132
- plus $587 from 14 others
What the payments were for
- Consulting fees$2,9255%
- Speaking & faculty fees$49,78284%
- Travel & lodging$2,9735%
- Food & beverage$3,7046%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 70 | $26,257 |
| Sanofi-aventis U.S. LLC | 47 | $22,561 |
| Lilly USA, LLC | 39 | $9,395 |
| Novo Nordisk | 21 | $301 |
| Dexcom, Inc. | 9 | $159 |
| Abbott | 18 | $132 |
| Sanofi | 1 | $72 |
| Tandem Diabetes Care, Inc. | 4 | $65 |
| Merck | 4 | $59 |
| AstraZeneca | 3 | $55 |
| Johnson & Johnson | 4 | $54 |
| IBSA Pharma Inc. | 3 | $45 |
| Medtronic | 3 | $43 |
| AbbVie | 3 | $42 |
| Corcept Therapeutics | 3 | $39 |
| Amgen | 2 | $37 |
| Lifescan, Inc. | 2 | $28 |
| Shire North American Group Inc | 2 | $24 |
| Insulet Corporation | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$34,137
- SOLIQUA 100/33$15,401
- TOUJEO$9,475
How this compares
$59,392 in reported general payments places this provider in the 85th percentile of 76 endocrinology, diabetes & metabolism providers in Oregon.
See all endocrinology, diabetes & metabolism providers in Oregon →
Other endocrinology, diabetes & metabolism in Portland
- Michael McClungPortland$1.3M
- Maria FleseriuPortland$464K
- James NeifingPortland$311K
- Rodica BusuiPortland$255K
- Jonathan PurnellPortland$212K
- Eric OrwollPortland$94K
- Paul DuellPortland$91K
- Sergio FazioPortland$88K
- Andrew AhmannPortland$56K
- Matthew RiddlePortland$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.